* Ultralife Corp ULBI.OQ ULBI.O is expected to show a
fall in
quarterly revenue when it reports results on April 27.
* The Newark New York New York-based company is expected to
report a 11.1% decrease in revenue to $27 million from $30.37
million a year ago, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Ultralife Corp is
for a
loss of 10 cents per share.
* The one available analyst rating on the shares is "buy".
* The average consensus recommendation for the electrical
components & equipment peer group is also "Buy".
* Wall Street's median 12-month price target for Ultralife
Corp is
$12, above its last closing price of $4.05.
This summary was machine generated April 25 at 18:31 GMT. All
figures in US dollars unless otherwise stated